SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-264493
Filing Date
2021-09-02
Accepted
2021-09-02 16:05:50
Documents
14
Period of Report
2021-09-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d88078d8k.htm   iXBRL 8-K 24875
2 EX-99.1 d88078dex991.htm EX-99.1 8612
6 GRAPHIC g88078g0902081516107.jpg GRAPHIC 5422
  Complete submission text file 0001193125-21-264493.txt   171076

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fbrx-20210902.xsd EX-101.SCH 2905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbrx-20210902_lab.xml EX-101.LAB 18886
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbrx-20210902_pre.xml EX-101.PRE 11868
7 EXTRACTED XBRL INSTANCE DOCUMENT d88078d8k_htm.xml XML 3484
Mailing Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502
Business Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502 (310) 618-6994
Forte Biosciences, Inc. (Filer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38052 | Film No.: 211233273
SIC: 2834 Pharmaceutical Preparations